Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04032704
Title A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | AUS

No variant requirements are available.